Successful Cosmetic Treatment in a Patient with Connective Tissue Disorder with Calcium Hydroxylapatite Filler - Case Report

Cao W, Arriel K and Chen WQ

Published on: 2023-07-14

Abstract

The use of cosmetic treatments in patients with connective tissue disorders (CTD) is a controversial topic due to concerns about disease reactivation. This case report describes the successful use of calcium hydroxylapatite (CaHA) filler in a patient with stable scleroderma. Various treatments have been attempted in CTD patients, including surgical procedures and injectable fillers. Recent studies have demonstrated the safety of dermal fillers in this patient population. CaHA fillers have biocompatible collagen-stimulating properties and a well-established safety profile. In this case, the patient underwent three sessions of CaHA injections over a span of one year and three months, resulting in improved skin quality and facial contour. Minimal adverse effects were reported, and the results were visible by the second month after each application. The study suggests that CaHA fillers can be a viable option for cosmetic correction in patients with CTD, but further research is needed to compare different fillers in terms of collagen induction, durability, and safety in this population. CaHA fillers offer a minimally invasive alternative to complex and costly procedures for facial contouring and rejuvenation in patients with stable CTD.